, Tracking Stock Market Picks
Enter Symbol:
Autodesk, Inc. (ADSK) [hlAlert]

Neutral ADSK
up 37.20 %

Autodesk, Inc. (ADSK) downgraded to Neutral with price target $54 by Rosenblatt

Posted on: Tuesday,  Nov 10, 2015  9:25 AM ET by Rosenblatt

Rosenblatt rated Neutral Autodesk, Inc. (NASDAQ: ADSK) on 11/10/2015. Previously Rosenblatt rated Buy Autodesk, Inc. (NASDAQ: ADSK) on 10/07/2015., when
the stock price was $45.23. Since then, Autodesk, Inc. has gained 37.21% as of 11/10/2015's recent price of $62.06.
If you would have followed the previous Rosenblatt's recommendation on ADSK, you would have gained 37.2% of your investment in 34 days.

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson?s disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/10/2015 9:25 AM Hold
62.06 54.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/7/2015 9:25 AM Buy
45.23 54.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy